The Boston Keratoprosthesis: Comparing Corneal Epithelial Cell Compatibility with Titanium and PMMA

被引:33
|
作者
Ament, Jared D. [1 ,2 ]
Spurr-Michaud, Sandra J. [1 ]
Dohlman, Claes H. [1 ,2 ]
Gipson, Ilene K. [1 ]
机构
[1] Harvard Univ, Sch Med, Schepens Eye Res Inst, Boston, MA 02114 USA
[2] Harvard Univ, Sch Med, Massachusetts Eye & Ear Infirm, Boston, MA 02114 USA
关键词
Boston Keratoprosthesis; biomaterials; titanium; corneal cell compatibility; INTRAOCULAR LENSES; RESIDUAL MONOMER; BIOMATERIALS; CYTOTOXICITY; PARTICLES; RESINS;
D O I
10.1097/ICO.0b013e31819670ac
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose: To determine in vitro whether titanium is superior corneal cell compatibility to standard polymethyl-methacryl ate (PMMA) for the Boston Keratoprosthesis (KPro). Methods: Human corneal-limbal epithelial (HCLE) cells were Cultured 24, 48, 72 96, 120, 144. or 168 hours in culture plates alone (controls) or with PMMA or titanium discs. Experiments were performed in triplicate and repeated (final n = 6). To determine if a Soluble, toxic factor is emitted from materials, concurrent experiments at 48 and 144 hours were performed with discs placed in Transwell Supports, with HCLE cells plated beneath. As an additional test for soluble factors, cells were incubated 24 hours with disc-conditioned media, and number of viable cells per well was quantified at each timepoint by proliferation assay. To determine if delayed cell proliferation was attributable to cell death, HCLE cell death was measured under all conditions and quantified at each timepoint by cytotoxicity assay. The effects of material on HCLE cell proliferation over time was determined by repeated measures ANOVA. P < 0.05 was statistically significant. Results: HCLE cell proliferation was greater in wells with titanium discs compared to PMMA. Differences between the test discs and control non-disc cocultures were statistically significant over time for both cell proliferation (P = 0.001) and death (P = 0.0025). No significant difference Was found using Transwells (P = 0.9836) or disc-conditioned media (P = 0.36). Conclusion: This in vitro HCLE cell model demonstrates significantly increased cell proliferation and decreased cell death with cell/titanium contact compared to cell/PMNA contact. Moreover, differences are unlikely attributable to a soluble factor. Prospective in vivo analysis of the two KPro biomaterials is indicated.
引用
收藏
页码:808 / 811
页数:4
相关论文
共 50 条
  • [41] Intra-operative optical coherence tomography in corneal lamellar graft reinforcement for Boston type I keratoprosthesis corneal melt
    Zeng, Liangbo
    Chen, Miao
    Lin, Lixia
    Zhai, Jiajie
    Chen, Jiaqi
    Gu, Jianjun
    INDIAN JOURNAL OF OPHTHALMOLOGY, 2023, 71 (07) : 2892 - 2896
  • [42] In Vitro Compatibility of Contact Lenses With Corneal Epithelial Cells
    Vijay, Ajay K.
    Fadli, Zohra
    Lakkis, Carol
    Coles-Brennan, Chantal
    Willcox, Mark D. P.
    EYE & CONTACT LENS-SCIENCE AND CLINICAL PRACTICE, 2018, 44 : S283 - S290
  • [43] Boston Type I Keratoprosthesis for Visual Rehabilitation in a Patient With Gelatinous Drop-Like Corneal Dystrophy
    Cortina, M. Soledad
    Porter, Isaac W.
    Sugar, Joel
    de la Cruz, Jose
    CORNEA, 2012, 31 (07) : 844 - 845
  • [44] Frozen versus fresh corneal graft carriers in Boston keratoprosthesis surgery: 10-year outcomes
    Sabeti, Saama
    Daoud, Roy
    Robert, Marie-Claude
    Harissi-Dagher, Mona
    CANADIAN JOURNAL OF OPHTHALMOLOGY-JOURNAL CANADIEN D OPHTALMOLOGIE, 2022, 57 (02): : 127 - 133
  • [45] The treatment of end-stage corneal disease: penetrating keratoplasty compared with Boston type 1 keratoprosthesis
    Bonneau, Steven
    Tong, C. Maya
    Yang, Yelin
    Harissi-Dagher, Mona
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2022, 260 (09) : 2781 - 2790
  • [46] Epithelial growth over the optic surface of the type 1 Boston Keratoprosthesis: histopathology and implications for biointegration
    Khalifa, Yousuf M.
    Davis, Don
    Mamalis, Nick
    Moshirfar, Majid
    CLINICAL OPHTHALMOLOGY, 2010, 4 : 1069 - 1071
  • [47] Treatment of Refractory Keratitis After a Boston Type I Keratoprosthesis With Corneal Collagen Cross-Linking
    Zarei-Ghanavati, Siamak
    Irandoost, Fatemeh
    CORNEA, 2015, 34 (09) : 1161 - 1163
  • [48] The treatment of end-stage corneal disease: penetrating keratoplasty compared with Boston type 1 keratoprosthesis
    Steven Bonneau
    C. Maya Tong
    Yelin Yang
    Mona Harissi-Dagher
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2022, 260 : 2781 - 2790
  • [49] BOSTON TYPE 1 KERATOPROSTHESIS, SURGICAL RESULTS AND EARLY EXPERIENCE FROM A TERTIARY REFERRAL CORNEAL UNIT
    Moloney, Greg T.
    Tan, Johnson C. H.
    McCarthy, Martin
    CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2013, 41 : 76 - 76
  • [50] Type 1 Boston Keratoprosthesis for Limbal Stem Cell Deficiency in Epidermolysis Bullosa
    Modabber, Milad
    Harissi-Dagher, Mona
    OCULAR IMMUNOLOGY AND INFLAMMATION, 2019, 27 (02) : 285 - 286